Showing results (21-30 of 252) with videos related to
Sort By:
Pageof 26
Leukemia Research|December 4, 2014
The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromesLing Zhang, Eric Padron, Jeffrey LancetExpert Review of Hematology|February 17, 2011
Biology and treatment of the 5q- syndromeEric Padron, Rami Komrokji, Alan F ListCurrent Treatment Options in Oncology|October 28, 2018
Current Management and Recent Advances in the Treatment of Chronic Myelomonocytic LeukemiaAnthony M Hunter, Ling Zhang, Eric PadronClinical Advances in Hematology & Oncology : H&O|June 14, 2014
The clinical management of chronic myelomonocytic leukemiaEric Padron, Rami Komrokji, Alan F ListBest Practice & Research. Clinical Haematology|April 1, 2019
TP53 and therapy-related myeloid neoplasmsJae Chung, David A Sallman, Eric PadronBest Practice & Research. Clinical Haematology|December 6, 2021
It is time to shift the treatment paradigm in myelodysplastic syndromes: A focus on novel developments and current investigational approaches exploring combinatorial therapy in high-risk MDSLuis E Aguirre, Rami Komrokji, Eric PadronCurrent Treatment Options in Oncology|October 4, 2011
The 5q- syndrome: biology and treatmentEric Padron, Rami Komrokji, Alan F ListBlood|October 7, 2016
When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemiaMarkus Ball, Alan F List, Eric PadronCancer Biology & Medicine|November 4, 2016
Clinical management of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromesJoseph A Clara, David A Sallman, Eric PadronDiseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|September 3, 2020
Accuracy of Achalasia Quality of Life and Eckardt scores for assessment of clinical improvement post treatment for achalasiaSamuel Slone, Ambuj Kumar, John Jacobs, et al.Pageof 26